Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy Hanna

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Radiology|May 17, 2012
Positive predictive value of BI-RADS MR imagingMary C Mahoney, Constantine Gatsonis, Lucy Hanna, et al.
Substance Abuse|December 6, 2002
Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of IncarcerationJennifer G. Clarke, Michael D. Stein, Lucy Hanna, et al.
AJR. American Journal of Roentgenology|August 24, 2012
Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trialWendy B DeMartini, Lucy Hanna, Constantine Gatsonis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Breast Imaging|February 15, 2020
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-upNanette D Debruhl, Su-Ju Lee, Mary C Mahoney, et al.
The Oncologist|July 13, 2016
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET RegistryRathan M Subramaniam, Anthony F Shields, Archana Sachedina, et al.
Molecular Imaging and Biology|November 17, 2010
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET RegistryBruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2017
Intended Versus Inferred Treatment After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET RegistryBruce E Hillner, Lucy Hanna, Rajesh Makineni, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Radiology|May 17, 2012
Positive predictive value of BI-RADS MR imagingMary C Mahoney, Constantine Gatsonis, Lucy Hanna, et al.
Substance Abuse|December 6, 2002
Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of IncarcerationJennifer G. Clarke, Michael D. Stein, Lucy Hanna, et al.
AJR. American Journal of Roentgenology|August 24, 2012
Evaluation of tissue sampling methods used for MRI-detected contralateral breast lesions in the American College of Radiology Imaging Network 6667 trialWendy B DeMartini, Lucy Hanna, Constantine Gatsonis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Breast Imaging|February 15, 2020
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-upNanette D Debruhl, Su-Ju Lee, Mary C Mahoney, et al.
The Oncologist|July 13, 2016
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET RegistryRathan M Subramaniam, Anthony F Shields, Archana Sachedina, et al.
Molecular Imaging and Biology|November 17, 2010
Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET RegistryBruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2017
Intended Versus Inferred Treatment After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET RegistryBruce E Hillner, Lucy Hanna, Rajesh Makineni, et al.
Pageof 4